U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    COL10A1 collagen type X alpha 1 chain [ Homo sapiens (human) ]

    Gene ID: 1300, updated on 5-Mar-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer.

    Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer.
    Xu S, Liu D, Qin Z, Liang Z, Xie H, Yi B, Wang K, Lin G, Liu R, Yang K, Xu Y, Zhang H., Free PMC Article

    01/29/2024
    COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.

    COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
    Xu Q, Zheng J, Su Z, Chen B, Gu S., Free PMC Article

    11/21/2023
    COL10A1 is a potential immunotherapy biomarker associated with immune infiltration and deficient mismatch repair in colon cancer.

    COL10A1 is a potential immunotherapy biomarker associated with immune infiltration and deficient mismatch repair in colon cancer.
    Cai S, Sun Z, Yan Y, Li W, Wu Q.

    09/23/2023
    Natural history and genetic spectrum of the Turkish metaphyseal dysplasia cohort, including rare types caused by biallelic COL10A1, COL2A1, and LBR variants.

    Natural history and genetic spectrum of the Turkish metaphyseal dysplasia cohort, including rare types caused by biallelic COL10A1, COL2A1, and LBR variants.
    Tüysüz B, Kasap B, Sarıtaş M, Alkaya DU, Bozlak S, Kıykım A, Durmaz A, Yıldırım T, Akpınar E, Apak H, Vural M.

    01/14/2023
    Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.

    Bioinformatics-Based Analysis: Noncoding RNA-Mediated COL10A1 Is Associated with Poor Prognosis and Immune Cell Infiltration in Pancreatic Cancer.
    Liu Q, Zhao H, Guo Y, Zhang K, Shang F, Liu T., Free PMC Article

    10/1/2022
    High COL10A1 expression potentially contributes to poor outcomes in gastric cancer with the help of LEF1 and Wnt2.

    High COL10A1 expression potentially contributes to poor outcomes in gastric cancer with the help of LEF1 and Wnt2.
    Zhang M, Jin M, Gao Z, Yu W, Zhang W., Free PMC Article

    09/24/2022
    VSNL1 Promotes Cell Proliferation, Migration, and Invasion in Colorectal Cancer by Binding with COL10A1.

    VSNL1 Promotes Cell Proliferation, Migration, and Invasion in Colorectal Cancer by Binding with COL10A1.
    He C, Liu W, Xiong Y, Wang Y, Pan L, Luo L, Tu Y, Song R, Chen W.

    04/9/2022
    Identification of a novel COL10A1: c.1952 G>T variant in a family with Schmid metaphyseal chondrodysplasia and development of a noninvasive prenatal testing method.

    Identification of a novel COL10A1: c.1952 G>T variant in a family with Schmid metaphyseal chondrodysplasia and development of a noninvasive prenatal testing method.
    Ye Y, Li W, Wang G, Zhan L, Lin J, Li T, Zhang J., Free PMC Article

    03/26/2022
    COL10A1 is a novel factor in the development of choroidal neovascularization.

    COL10A1 is a novel factor in the development of choroidal neovascularization.
    Lv D, Chen D, Wang Z, Cui Z, Ma JH, Ji S, Chen J, Tang S.

    03/12/2022
    Differentiation of Hypertrophic Chondrocytes from Human iPSCs for the In Vitro Modeling of Chondrodysplasias.

    Differentiation of Hypertrophic Chondrocytes from Human iPSCs for the In Vitro Modeling of Chondrodysplasias.
    Pretemer Y, Kawai S, Nagata S, Nishio M, Watanabe M, Tamaki S, Alev C, Yamanaka Y, Xue JY, Wang Z, Fukiage K, Tsukanaka M, Futami T, Ikegawa S, Toguchida J., Free PMC Article

    12/11/2021
    Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.

    Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
    Chen S, Wei Y, Liu H, Gong Y, Zhou Y, Yang H, Tang L., Free PMC Article

    11/22/2021
    Genome-Scale Analysis Identifies Novel Transcript-Variants in Esophageal Adenocarcinoma.

    Genome-Scale Analysis Identifies Novel Transcript-Variants in Esophageal Adenocarcinoma.
    Purkayastha BPD, Chan ER, Ravillah D, Ravi L, Gupta R, Canto MI, Wang JS, Shaheen NJ, Willis JE, Chak A, Varadan V, Guda K., Free PMC Article

    09/11/2021
    MiR-218 affects hypertrophic differentiation of human mesenchymal stromal cells during chondrogenesis via targeting RUNX2, MEF2C, and COL10A1.

    MiR-218 affects hypertrophic differentiation of human mesenchymal stromal cells during chondrogenesis via targeting RUNX2, MEF2C, and COL10A1.
    Melnik S, Gabler J, Dreher SI, Hecht N, Hofmann N, Großner T, Richter W., Free PMC Article

    08/7/2021
    Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.

    Collagen Type X Alpha 1 (COL10A1) Contributes to Cell Proliferation, Migration, and Invasion by Targeting Prolyl 4-Hydroxylase Beta Polypeptide (P4HB) in Breast Cancer.
    Yang W, Wu X, Zhou F., Free PMC Article

    06/5/2021
    Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.

    Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M, Chen H, Wang M, Bai F, Wu K., Free PMC Article

    03/20/2021
    Effect of miR-26a-5p on gastric cancer cell proliferation, migration and invasion by targeting COL10A1.

    Effect of miR-26a-5p on gastric cancer cell proliferation, migration and invasion by targeting COL10A1.
    Li HH, Wang JD, Wang W, Wang HF, Lv JQ.

    02/13/2021
    RNAseq-Based Prioritization Revealed COL6A5, COL8A1, COL10A1 and MIR146A as Common and Differential Susceptibility Biomarkers for Psoriasis and Psoriatic Arthritis: Confirmation from Genotyping Analysis of 1417 Italian Subjects.

    RNAseq-Based Prioritization Revealed COL6A5, COL8A1, COL10A1 and MIR146A as Common and Differential Susceptibility Biomarkers for Psoriasis and Psoriatic Arthritis: Confirmation from Genotyping Analysis of 1417 Italian Subjects.
    Caputo V, Strafella C, Termine A, Campione E, Bianchi L, Novelli G, Giardina E, Cascella R., Free PMC Article

    02/13/2021
    Two novel mutations were identified in the present study, which will facilitate diagnosis of Schmid-type metaphyseal chondrodysplasia and further expand the spectrum of the COL10A1 mutations associated with MCDS patients

    Identification of two novel COL10A1 heterozygous mutations in two Chinese pedigrees with Schmid-type metaphyseal chondrodysplasia.
    Kong L, Shi L, Wang W, Zuo R, Wang M, Kang Q., Free PMC Article

    02/15/2020
    MiR-384 down-regulated COL10A1 expression in the non-small cell lung cancer cells.

    MiR-384 induces apoptosis and autophagy of non-small cell lung cancer cells through the negative regulation of Collagen α-1(X) chain gene.
    Guo Q, Zheng M, Xu Y, Wang N, Zhao W., Free PMC Article

    02/1/2020
    three polymorphisms located in COL6A5, COL8A1, and COL10A1 were investigated as potential susceptibility biomarkers for atopic eczema.

    Atopic Eczema: Genetic Analysis of COL6A5, COL8A1, and COL10A1 in Mediterranean Populations.
    Strafella C, Caputo V, Minozzi G, Milano F, Arcangeli M, Sobhy N, Abdelmaksood R, Hashad D, Vakirlis E, Novelli G, Cascella R, Giardina E., Free PMC Article

    01/4/2020
    Schmid type metaphyseal chondrodysplasia (SMCD) is a rare skeletal dysplasia, characterized by short stature, short limbs, bowing of the legs, and radiographic features of metaphyseal irregularities with fraying and splaying, more severe at the knee. It is caused by mutations of the COL10A1 gene.

    Schmid Type Metaphyseal Chondrodysplasia with a Novel COL10A1 Mutation.
    Goyal M, Gupta A, Choudhary A, Bhandari A.

    12/7/2019
    This first report of individuals with a homozygous variant in COL10A1 defines a new type of autosomal recessive skeletal dysplasia. The observations in COL10A1 variant carriers suggest a phenotypic overlap between the mildest forms of metaphyseal chondrodysplasia, Schmid type (MCDS) and idiopathic short stature

    Autosomal recessive chondrodysplasia with severe short stature caused by a biallelic COL10A1 variant.
    Ain NU, Makitie O, Naz S.

    09/21/2019
    the disease mechanism involves the misfolding of the mutant protein causing increased endoplasmic reticulum (ER) stress and an unfolded protein response (UPR). However, in an iliac crest biopsy, the COL10A1 p.Y632X mutation was found to produce instability of the mutant mRNA such that little mutant protein may be produced.

    Carbamazepine reduces disease severity in a mouse model of metaphyseal chondrodysplasia type Schmid caused by a premature stop codon (Y632X) in the Col10a1 gene.
    Forouhan M, Sonntag S, Boot-Handford RP., Free PMC Article

    05/11/2019
    biomarkers suitable for the assessment of chronological ageing were identified, and extrapolated to the context of photo-damaged skin. In particular, KANK4, ACAN, Col XI alpha1, and PSG1, were expressed at an increased level in both chronologically-aged and photo-damaged skin.

    Genome-wide profiling of adult human papillary and reticular fibroblasts identifies ACAN, Col XI α1, and PSG1 as general biomarkers of dermis ageing, and KANK4 as an exemplary effector of papillary fibroblast ageing, related to contractility.
    Haydont V, Neiveyans V, Zucchi H, Fortunel NO, Asselineau D.

    04/27/2019
    Plasma samples from lung cancer patients and healthy heavy-smokers controls were tested for levels of COL11A1 and COL10A1 (n = 57 each) and SPARC (n = 90 each). Higher plasma levels of COL10A1 were detected in patients (p </= 0.001), a difference that was driven specifically by females (p < 0.001). No difference in COL11A1 levels between patients and controls was found

    Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer.
    Andriani F, Landoni E, Mensah M, Facchinetti F, Miceli R, Tagliabue E, Giussani M, Callari M, De Cecco L, Colombo MP, Roz L, Pastorino U, Sozzi G., Free PMC Article

    11/10/2018
    firstprevious page of 3 nextlast